Method and system for detecting lymphosarcoma in cats using biomarkers
US8969022B2 · kind B2 · utility
0Cited by
0References
1Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 8, 2012 |
| Grant date | Mar 3, 2015 |
| Priority date | — |
| Expiry date | Nov 8, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/912
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention provides a method and system for developing and using diagnoses of lymphosarcoma in feline subjects using thymidine kinase (TK) and haptoglobin (HP) as biomarkers. The invention provides a method for obtaining the level of each biomarker and computing an index for a feline subject. The invention provides predefined index ranges to which the index value may be matched in order to determine whether the subject has a high probability of being affected by lymphosarcoma, even when the subject shows apparent symptoms that may be common with inflammatory bowel disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.